Early treatment may stop swelling in head and neck cancer survivors

NCT ID NCT05937269

ENROLLING_BY_INVITATION Prevention Sponsor: The University of Texas Health Science Center, Houston Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether starting physiotherapy early—before any swelling appears—can prevent lymphedema in people treated for head and neck cancer. Twenty participants will either use a home compression device daily or receive standard care. Researchers will track swelling and use special imaging to see if early treatment makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: pneumatic compression therapy
What this could lead to: If it works, this could prevent lymphedema in head and neck cancer survivors, avoiding painful swelling and improving quality of life.
What could go wrong: This is a very small early-phase trial with only 20 participants, so results may not apply to everyone. The treatment requires daily home use, which may be hard to maintain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms lymphedema prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK CANCER LYMPHEDEMA OF FACE

Contacts and locations

Locations

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.